Ó£ÌÒÊÓƵ

Featured on Massive Science: how Ó£ÌÒÊÓƵ's breakthrough opti-oxâ„¢ technology is being used by cultured meat company Meatable.

Ó£ÌÒÊÓƵ wins Biotech Company of the Year at the Cambridge Independent Science andTechnology awards.

SynbioBeta CEO John Cumbers talks reimagining cell therapies through cell reprogramming with Rick Klausner and Ó£ÌÒÊÓƵ CEO.

Dr Farah Patell-Socha, VP of Research Products discusses the launch of ioSkeletal Myocytes.

The first episode in our special three part mini-series.

IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.

Ó£ÌÒÊÓƵ CEO spoke about reprogramming human cells at the TEDxCambridgeUniversity ‘Untangling networks’ event.

Today Meatable announced their Series A fundraise of $47 million. Read about the connection to Ó£ÌÒÊÓƵ.